A sclerostin super-producer cell line derived from the human cell line SaOS-2: A new tool for the study of the molecular mechanisms driving sclerostin expression

Flor M. Pérez-Campo, Carolina Sañudo, Jesus Delgado-Calle, Jana Arozamena, María T. Zarrabeitia, José A. Riancho

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Sclerostin, the product of the SOST gene, is a key regulator of bone homeostasis. Sclerostin interferes with the Wnt signalling pathway and, therefore, has a negative effect on bone formation. Although the importance of sclerostin in bone homeostasis is well established, many aspects of its biology are still unknown. Due to its restricted pattern of expression, in vitro studies of SOST gene regulation are technically challenging. Furthermore, a more profound investigation of the molecular mechanism controlling sclerostin expression has been hampered by the lack of a good human in vitro model. Here, we describe two cell lines derived from the human osteosarcoma cell line SaOS-2 that produce elevated levels of sclerostin. Analysis of the super-producer cell lines showed that sclerostin levels were still reduced in response to parathyroid hormone treatment or in response to mechanical loading, indicating that these regulatory mechanisms were not affected in the presented cell lines. In addition, we did not find differences between the promoter or ECR5 sequences of our clones and the SaOS-2 parental line. However, the methylation of the proximal CpG island located at the SOST promoter was lower in the super-producer clones, in agreement with a higher level of SOST transcription. Although the underlying biological causes of the elevated levels of sclerostin production in this cell line are not yet clear, we believe that it could be an extremely useful tool to study the molecular mechanisms driving sclerostin expression in humans.

Original languageEnglish (US)
Pages (from-to)194-199
Number of pages6
JournalCalcified Tissue International
Volume95
Issue number2
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Cell Line
Homeostasis
Clone Cells
Bone and Bones
CpG Islands
Wnt Signaling Pathway
Osteosarcoma
Parathyroid Hormone
Osteogenesis
Methylation
Genes
In Vitro Techniques

Keywords

  • Bone homeostasis
  • Osteoporosis
  • SaOS-2 human cell line
  • Sclerostin

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medicine(all)

Cite this

A sclerostin super-producer cell line derived from the human cell line SaOS-2 : A new tool for the study of the molecular mechanisms driving sclerostin expression. / Pérez-Campo, Flor M.; Sañudo, Carolina; Delgado-Calle, Jesus; Arozamena, Jana; Zarrabeitia, María T.; Riancho, José A.

In: Calcified Tissue International, Vol. 95, No. 2, 2014, p. 194-199.

Research output: Contribution to journalArticle

Pérez-Campo, Flor M. ; Sañudo, Carolina ; Delgado-Calle, Jesus ; Arozamena, Jana ; Zarrabeitia, María T. ; Riancho, José A. / A sclerostin super-producer cell line derived from the human cell line SaOS-2 : A new tool for the study of the molecular mechanisms driving sclerostin expression. In: Calcified Tissue International. 2014 ; Vol. 95, No. 2. pp. 194-199.
@article{16ec7be6cb7f4ce7a349e4c49a27e71e,
title = "A sclerostin super-producer cell line derived from the human cell line SaOS-2: A new tool for the study of the molecular mechanisms driving sclerostin expression",
abstract = "Sclerostin, the product of the SOST gene, is a key regulator of bone homeostasis. Sclerostin interferes with the Wnt signalling pathway and, therefore, has a negative effect on bone formation. Although the importance of sclerostin in bone homeostasis is well established, many aspects of its biology are still unknown. Due to its restricted pattern of expression, in vitro studies of SOST gene regulation are technically challenging. Furthermore, a more profound investigation of the molecular mechanism controlling sclerostin expression has been hampered by the lack of a good human in vitro model. Here, we describe two cell lines derived from the human osteosarcoma cell line SaOS-2 that produce elevated levels of sclerostin. Analysis of the super-producer cell lines showed that sclerostin levels were still reduced in response to parathyroid hormone treatment or in response to mechanical loading, indicating that these regulatory mechanisms were not affected in the presented cell lines. In addition, we did not find differences between the promoter or ECR5 sequences of our clones and the SaOS-2 parental line. However, the methylation of the proximal CpG island located at the SOST promoter was lower in the super-producer clones, in agreement with a higher level of SOST transcription. Although the underlying biological causes of the elevated levels of sclerostin production in this cell line are not yet clear, we believe that it could be an extremely useful tool to study the molecular mechanisms driving sclerostin expression in humans.",
keywords = "Bone homeostasis, Osteoporosis, SaOS-2 human cell line, Sclerostin",
author = "P{\'e}rez-Campo, {Flor M.} and Carolina Sa{\~n}udo and Jesus Delgado-Calle and Jana Arozamena and Zarrabeitia, {Mar{\'i}a T.} and Riancho, {Jos{\'e} A.}",
year = "2014",
doi = "10.1007/s00223-014-9880-5",
language = "English (US)",
volume = "95",
pages = "194--199",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - A sclerostin super-producer cell line derived from the human cell line SaOS-2

T2 - A new tool for the study of the molecular mechanisms driving sclerostin expression

AU - Pérez-Campo, Flor M.

AU - Sañudo, Carolina

AU - Delgado-Calle, Jesus

AU - Arozamena, Jana

AU - Zarrabeitia, María T.

AU - Riancho, José A.

PY - 2014

Y1 - 2014

N2 - Sclerostin, the product of the SOST gene, is a key regulator of bone homeostasis. Sclerostin interferes with the Wnt signalling pathway and, therefore, has a negative effect on bone formation. Although the importance of sclerostin in bone homeostasis is well established, many aspects of its biology are still unknown. Due to its restricted pattern of expression, in vitro studies of SOST gene regulation are technically challenging. Furthermore, a more profound investigation of the molecular mechanism controlling sclerostin expression has been hampered by the lack of a good human in vitro model. Here, we describe two cell lines derived from the human osteosarcoma cell line SaOS-2 that produce elevated levels of sclerostin. Analysis of the super-producer cell lines showed that sclerostin levels were still reduced in response to parathyroid hormone treatment or in response to mechanical loading, indicating that these regulatory mechanisms were not affected in the presented cell lines. In addition, we did not find differences between the promoter or ECR5 sequences of our clones and the SaOS-2 parental line. However, the methylation of the proximal CpG island located at the SOST promoter was lower in the super-producer clones, in agreement with a higher level of SOST transcription. Although the underlying biological causes of the elevated levels of sclerostin production in this cell line are not yet clear, we believe that it could be an extremely useful tool to study the molecular mechanisms driving sclerostin expression in humans.

AB - Sclerostin, the product of the SOST gene, is a key regulator of bone homeostasis. Sclerostin interferes with the Wnt signalling pathway and, therefore, has a negative effect on bone formation. Although the importance of sclerostin in bone homeostasis is well established, many aspects of its biology are still unknown. Due to its restricted pattern of expression, in vitro studies of SOST gene regulation are technically challenging. Furthermore, a more profound investigation of the molecular mechanism controlling sclerostin expression has been hampered by the lack of a good human in vitro model. Here, we describe two cell lines derived from the human osteosarcoma cell line SaOS-2 that produce elevated levels of sclerostin. Analysis of the super-producer cell lines showed that sclerostin levels were still reduced in response to parathyroid hormone treatment or in response to mechanical loading, indicating that these regulatory mechanisms were not affected in the presented cell lines. In addition, we did not find differences between the promoter or ECR5 sequences of our clones and the SaOS-2 parental line. However, the methylation of the proximal CpG island located at the SOST promoter was lower in the super-producer clones, in agreement with a higher level of SOST transcription. Although the underlying biological causes of the elevated levels of sclerostin production in this cell line are not yet clear, we believe that it could be an extremely useful tool to study the molecular mechanisms driving sclerostin expression in humans.

KW - Bone homeostasis

KW - Osteoporosis

KW - SaOS-2 human cell line

KW - Sclerostin

UR - http://www.scopus.com/inward/record.url?scp=84905562947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905562947&partnerID=8YFLogxK

U2 - 10.1007/s00223-014-9880-5

DO - 10.1007/s00223-014-9880-5

M3 - Article

C2 - 24913258

AN - SCOPUS:84905562947

VL - 95

SP - 194

EP - 199

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 2

ER -